The Potential ROI for Covering GLP-1s, Workspan Daily Plus+ article Beyond the Rx: Maximizing GLP-1 Value Through Employee Support, Workspan Daily Plus+ article A Prescription for Rising Drug Costs, Workspan Magazine article For Everyone What Does the Data Show on GLP-1 Prescribe Rates, Coverage, Costs
While the absolute risk remains low (roughly 0.23 percent in the STEP trials), higher doses may amplify this risk
It also affects employees in non-safety-sensitive jobs
Hindbrain glucagon-like peptide-1 neurons track intake volume and contribute to injection stress-induced hypophagia in meal-entrained rats
As with any treatment, it is important to consider both the potential benefits and risks
"It was amazing to be back in the ballroom," Savchenko told E